Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-7.54 Insider Own- Shs Outstand3.80M Perf Week12.76%
Market Cap2.49M Forward P/E- EPS next Y-1.39 Insider Trans- Shs Float1.12M Perf Month-7.89%
Income-8.43M PEG- EPS next Q-0.63 Inst Own5.11% Short Float1.15% Perf Quarter-11.73%
Sales0.00M P/S- EPS this Y69.16% Inst Trans- Short Ratio0.25 Perf Half Y-85.81%
Book/sh2.40 P/B0.27 EPS next Y53.24% ROA-48.76% Short Interest0.01M Perf Year-88.53%
Cash/sh3.87 P/C0.17 EPS next 5Y- ROE-84.12% 52W Range0.57 - 12.00 Perf YTD-86.66%
Dividend Est.- P/FCF- EPS past 5Y67.35% ROI-92.36% 52W High-94.55% Beta1.99
Dividend TTM- Quick Ratio3.61 Sales past 5Y0.00% Gross Margin- 52W Low14.75% ATR (14)0.04
Dividend Ex-Date- Current Ratio3.61 EPS Y/Y TTM83.73% Oper. Margin0.00% RSI (14)52.99 Volatility5.11% 5.94%
Employees4 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.67 Target Price5.48
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q52.79% Payout- Rel Volume0.23 Prev Close0.66
Sales Surprise- EPS Surprise-46.05% Sales Q/Q- EarningsMay 09 BMO Avg Volume50.87K Price0.65
SMA206.63% SMA50-5.71% SMA200-74.68% Trades Volume11,779 Change-0.29%
Jun-27-24 08:00AM
Jun-25-24 04:05PM
Jun-12-24 08:00AM
May-09-24 08:30AM
May-02-24 04:10PM
10:52AM Loading…
Mar-15-24 10:52AM
Mar-13-24 04:05PM
Mar-07-24 04:05PM
Mar-05-24 08:34AM
Mar-04-24 08:00AM
Feb-14-24 09:00AM
Feb-08-24 08:00AM
Dec-13-23 08:30AM
Nov-10-23 12:19PM
05:46PM Loading…
Nov-08-23 05:46PM
Nov-03-23 08:41AM
Oct-24-23 09:32AM
Oct-02-23 12:25PM
Aug-09-23 08:30AM
Aug-02-23 04:45PM
Jul-27-23 08:00AM
May-24-23 08:15AM
May-08-23 05:00PM
May-02-23 08:30AM
Mar-22-23 09:13AM
Mar-21-23 08:30AM
Mar-11-23 02:59AM
Mar-08-23 05:08PM
04:05PM Loading…
Mar-02-23 04:05PM
Mar-01-23 08:30AM
Feb-22-23 08:39AM
Dec-13-22 08:30AM
Dec-05-22 11:15AM
Nov-10-22 08:30AM
Nov-03-22 07:00AM
Nov-01-22 08:30AM
Oct-18-22 08:30AM
Sep-13-22 08:30AM
Aug-23-22 01:43PM
Aug-18-22 07:00AM
Aug-11-22 04:30PM
Aug-09-22 04:23PM
Aug-05-22 09:28AM
Jul-28-22 08:30AM
Jul-18-22 11:43AM
Jul-15-22 08:30AM
Jul-06-22 08:30AM
Jun-15-22 04:01PM
Jun-14-22 08:30AM
Jun-10-22 10:23AM
Jun-06-22 11:22AM
May-23-22 08:30AM
May-17-22 08:30AM
May-11-22 11:24AM
Apr-25-22 01:05PM
Mar-24-22 08:30AM
Mar-15-22 08:41AM
Mar-10-22 08:00AM
Mar-01-22 08:00AM
Feb-17-22 08:00AM
Feb-10-22 08:00AM
Feb-08-22 08:30AM
Jan-26-22 08:00AM
Jan-24-22 07:15AM
Dec-15-21 09:00AM
Dec-14-21 08:30AM
Nov-16-21 08:30AM
Nov-11-21 08:30AM
Nov-08-21 08:00AM
Nov-04-21 09:25AM
Nov-02-21 08:30AM
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANGER DENNISDirectorJun 07 '24Sale0.7329721753Jun 10 04:10 PM